SC ENGINEERING CO., LTD
Financials
Valuation Metrics
SC ENGINEERING CO., LTD's Market Cap is ₩370B. At end of 2025 it was ₩494B. Ranked #1930 of 2,436 in KR market (top 79%), #726 of 787 on KOSPI (top 92%), #313 of 365 in Capital Goods (top 86%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 37.05B KRW | KR#1,930/2,436 Sec#313/365 |
| Revenue | 155.53B KRW | KR#1,148/2,436 Sec#195/365 |
| Net Income | -6.37B KRW | KR—/2,436 Sec—/365 |
| Total Assets | 122.48B KRW | KR#1,608/2,436 Sec#265/365 |
| Net Assets | 44.50B KRW | KR#1,955/2,436 Sec#310/365 |
| Employees | 177 | KR#1,172/2,436 Sec#188/365 |
| Value | ||
| P/B | 0.83x | KR#1,325/2,436 Sec#176/365 |
| P/S | 0.24x | KR#456/2,436 Sec#66/365 |
| FCF Yield | -19.93% | KR—/2,436 Sec—/365 |
| Profitability | ||
| ROE | -14.32% | KR#1,979/2,436 Sec#292/365 |
| ROA | -5.20% | KR#1,900/2,436 Sec#288/365 |
| Op. Margin | -3.50% | KR#1,808/2,436 Sec#266/365 |
| Revenue Growth | -46.56% | KR#2,269/2,436 Sec#330/365 |
| Financial Health | ||
| Debt Ratio | 275.22% | KR#2,073/2,436 Sec#297/365 |
| Total Debt | 29.45B KRW | KR#1,198/2,436 Sec#212/365 |
| FCF | -7.38B KRW | KR#1,616/2,436 Sec#234/365 |
| Cash | 33.62B KRW | KR#939/2,436 Sec#163/365 |
| Current Ratio | 0.83x | KR#2,010/2,436 Sec#320/365 |
| Performance | ||
| 1Y Return | -22.70% | KR#1,349/2,436 Sec#228/365 |
| 1M Return | -4.88% | KR#1,387/2,436 Sec#149/365 |
| From 52W High | -50.26% | KR#1,201/2,436 Sec#158/365 |
| 1Y MDD | -53.04% | KR#1,061/2,436 Sec#135/365 |
| Trading | ||
| Volume | 49,782 shares | KR#1,334/2,436 Sec#234/365 |
| Foreign Own. | 2.05% | KR—/2,436 Sec—/365 |
| Per Share | ||
| EPS | -171 KRW | KR—/2,436 Sec—/365 |
| BPS | 1,170 KRW | KR#2,247/2,436 Sec#348/365 |
Company Info
S.C. Engineering, founded in 1971 as a Miwon Group affiliate and listed in 1997, specializes in industrial plant design and construction for precision chemistry, pharmaceuticals, and food. Its subsidiary, Cellontech, produces and sells biocollagen-based therapeutic materials, develops complex biomaterials, and commercializes biopharmaceutical delivery systems. The company is adopting advanced technologies like module plants and smart factories, while also diversifying into health functional food distribution. S.C. Engineering is headquartered in Gangseo-gu, Seoul.